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INTRODUCTION
Water channel protein family, AQPs, is con-
sisted of a group of membrane proteins which fa-
cilitate water movement across the plasma mem-
brane. There are 13 types of AQPs in mammalian
tissues and they are distributed in almost all types
of the tissue. A member of the family, AQP5 had
been identified in various glandular tissues of exo-
crine type (1, 2) including the SMG (3). The SMG
is controlled by parasympathetic nerves and inner-
vated through chorda tympani. Previous report on
the effect of CTD showed that AQP5 protein levels
in the rat SMG were significantly decreased (4). To
clarify the cause of AQP5 down-regulation, we ana-
lyzed the possible mechanism in this study.
METHODS
Seven -week -old male Sprague -Dawley rats,
weighing 170-190 gram were purchased from SLC
(Shizuoka, Japan). Some of them are known to ex-
press a mutant AQP5, which expression at the aci-
nar cell membrane in the SMG is extremely re-
duced (5). Rats with normal AQP5 sequences were
therefore selected for the present study. Chorda
tympani denervation was performed under anesthe-
sia with Nembutal (sodium pentobarbital, 50 mg/kg
body weight) as described previously (6). All the
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experimental protocol was approved by the Animal
Ethical Committee of the University of Tokushima.
The SMG tissues were processed for the assay for
lysosomal enzymes activity, Western blotting, North-
ern blotting, and immunohistochemistry. Some of
the untreated rats were sacrificed for preparation of
the total membrane fraction and the SMG extract,
which samples were subjected to the in vitro deg-
radation assay of AQP5.
RESULTS AND DISCUSSION
Effects of CTD on the SMG weight and the AQP5
expression level were examined. After CTD, the
SMG weight was decreased but only for 1 week
(Fig. 1a). The AQP5 level, on the other hand,
continuously decreased until week 4 (Fig. 1b).
Western blotting of AQP1 and Na+K+ATPase α -
subunit showed a similar decrease. Administration
of cevimeline hydrochloride (CM), an M3 mus-
carinic agonist, recovered the AQP5 and AQP1 pro-
tein levels reduced by CTD, but not the protein lev-
els of Na+K+ATPase α -subunit. Also, another mem-
brane protein, dipeptidyl peptidase IV was scarcely
affected by CTD and CM administration. These re-
sults suggested the selectivity of AQP5 protein re-
duction following CTD and/or effects of CM.
Northern blotting and real-time PCR experiments
showed that the level of AQP5 mRNA was not af-
fected by CTD suggesting that AQP5 mRNA tran-
scription was not involved in the decrease of AQP5
protein levels. However, treatment of the CTD rats
Figure 1 Effects of CTD on the weight and AQP5 protein levels of rat SMG. a. Relative weight of SMG between non-treated (NT)
samples and denervated samples (CTD). b. Ratios of AQP5 protein levels of NT and CTD samples. Turkey’s multiple analysis was
then applied as a post hoc test. P0.05, P0.01, significantly different from the NT group before the operation (0 wk). Modi-
fied from Li, et al. (4).
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by chloroquine suppressed AQP5 reduction after the
operation. Since chloroquine is a lysosomal denatur-
ant, such results suggest involvement of the lysoso-
mal degradation pathway in AQP5 reduction fol-
lowing CTD. The in vitro experiments showed that
AQP5 can be degraded by the SMG extract which
contains various proteolytic enzymes. The degrada-
tion experiment using inhibitors for aspartic pro-
teases, serine/threonine proteases, and cysteine
proteases showed that cathepsin B, one of cysteine
proteases in the SMG extract, was responsible for
AQP5 degradation. Since cathepsin B is a lysosomal
enzyme, and since this result implied the involve-
ment of lysosome, immunohistochemistry of AQP5
and LAMP-2, a lysosomes marker was conducted ;
the results showed that the two proteins were co-
localized, suggesting that AQP5 is degraded in ly-
sosomes by cathepsin B (Fig. 2a). However, the
ratio of co-localized structure among the total AQP5
positive structures was not altered after CTD and
remained same, implying that degradation by this
pathway was not elevated by CTD (Fig. 2b, c, d).
By Western blotting, on the other hand, LC3-II,
an autophagy marker (7), potentially increased at
day 1 after CTD and gradually decreased thereafter
which suggested that CTD activated autophagy. The
number of LC3 positive structure was shown to be
co-localized with AQP5 and significantly increased
at day 1 after CTD, suggesting that autophagy is in-
volved in AQP5 degradation.
CONCLUSION
In acinar cells of the rat SMG, AQP5 was shown
to be degraded in lysosomes by cathepsin B al-
though this process was not elevated by CTD. CTD
Figure 2 Confocal image of co- localization of AQP5 and LAMP-2, a lysosomal marker, in frozen section of the rat SMG tissue. a.
Sample of non-treated rat. b. 1 day after CTD. c. 7 days after CTD. d. 14 days after CTD. Anti -AQP5 antibody of acinar cells was la-
beled with green fluorescence of 549 Alexa whereas LAMP-2, with punctate red fluorescence of 488 Alexa. The number of co-
localization between the two antibodies was not elevated after CTD.
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rather activated autophagy which was suggested to
degrade AQP5 consequently.
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